≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Alopecia areata

DOID EFO Endpoint Browser PheWeb

L12_ALOPECAREATA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L63
  • Hospital discharge: ICD-9 — 7040B|7040C
  • Hospital discharge: ICD-8 — 70400
  • Cause of death: ICD-10 — L63
  • Cause of death: ICD-9 — 7040B|7040C
  • Cause of death: ICD-8 — 70400

2 out of 7 registries used, show all original rules.

1003

4. Check minimum number of events

None

1003

5. Include endpoints

None

1003

6. Filter based on genotype QC (FinnGen only)

1003

Control definitions (FinnGen only)

Control exclude
L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L60-L75
Name in latin
Alopecia areata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7560 5187 2341
Only index persons 7028 4903 2125
Unadjusted period prevalence (%)
Whole population 0.12 0.15 0.07
Only index persons 0.15 0.18 0.08
Median age at first event (years)
Whole population 32.57 36.09 24.73
Only index persons 33.86 37.07 26.45

-FinnGen-

Key figures

All Female Male
Number of individuals 1003 781 222
Unadjusted period prevalence (%) 0.23 0.27 0.10
Median age at first event (years) 43.58 43.86 42.59

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
909
Matched controls
9088
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L63.9
ICD-10 Finland
Alopecia areata, unspecified
1271.8
323.0
454
7
L63.8
ICD-10 Finland
Other alopecia areata
3540.9
323.0
387
*
L63.0
ICD-10 Finland
Alopecia (capitis) totalis
+∞
169.2
157
*
D07AC01
ATC
betamethasone; topical
5.1
111.2
518
1884
L63.1
ICD-10 Finland
Alopecia universalis
+∞
100.9
95
*
D07AD01
ATC
clobetasol; topical
5.6
86.8
299
733
L63
ICD-10 Finland
Alopecia areata
113.6
85.7
92
9
D07AC13
ATC
mometasone; topical
4.1
79.8
438
1694
S23
ICPC
Hair loss/baldness
34.3
47.0
61
19
D07AB02
ATC
hydrocortisone butyrate; topical
3.0
45.5
351
1576
70400
ICD-8 Finland
Diseases of hair and hair follicles, Alopecia areata (benigna, maligna)
+∞
38.8
37
*
E0000UV
ATC
NA
2.5
37.3
452
2573
L64.9
ICD-10 Finland
Androgenic alopecia, unspecified
187.2
35.0
36
*
L65.9
ICD-10 Finland
Nonscarring hair loss, unspecified
70.4
30.1
34
5
H02AB06
ATC
prednisolone; systemic
2.2
29.0
451
2782
XQ802
NOMESCO Finland
Epicutan test
5.4
27.4
85
169
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
26.3
120
351
D07AA02
ATC
hydrocortisone; topical
2.8
24.6
185
770
TQW80
NOMESCO Finland
Local dermatologic skincare
8.7
23.9
52
63
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.9
19.8
133
513
L20.0
ICD-10 Finland
Besnier prurigo
3.0
18.8
113
405
D07XC01
ATC
betamethasone, combinations; topical
2.8
18.2
124
482
E000002
ATC
NA
2.6
17.9
144
617
D07AB08
ATC
desonide; topical
2.7
17.5
127
513
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.3
17.0
180
889
L64.8
ICD-10 Finland
Other androgenic alopecia
+∞
16.7
16
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.7
16.4
122
499
E000001
ATC
NA
2.0
14.7
213
1195
D02AE01
ATC
carbamide; topical
3.1
14.6
84
292
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.4
14.3
131
599
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
7.2
13.9
33
47
L71.8
ICD-10 Finland
Other rosacea
26.2
13.4
18
7
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
12.5
204
1191
H03AA01
ATC
levothyroxine sodium; systemic
1.8
11.8
228
1410
L65.8
ICD-10 Finland
Other specified nonscarring hair loss
65.8
11.6
13
*
70401
ICD-8 Finland
Diseases of hair and hair follicles, Alopecia alia sive NUD
+∞
11.5
11
*
XQ845
NOMESCO Finland
Dermatoscopy
9.8
11.3
22
23
D11AH01
ATC
tacrolimus; topical
9.4
11.0
22
24
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.5
10.9
51
153
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
10.5
123
627
7040B
ICD-9 Finland
Diseases of hair and hair follicles, Alopecia[ALOPECIA AREATA]
+∞
10.4
10
*
L73.8
ICD-10 Finland
Other specified follicular disorders
32.9
10.3
13
*
R06AX27
ATC
desloratadine; oral
1.7
10.3
282
1922
L80
ICD-10 Finland
Vitiligo
23.7
10.3
14
6
L04AD01
ATC
ciclosporin; systemic
5.1
10.2
31
62
XQ848
NOMESCO Finland
Dermatological photography
5.2
10.1
30
59
E000003
ATC
NA
3.0
10.1
57
196
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
10.0
308
2168
R06AE07
ATC
cetirizine; oral
1.6
9.6
408
3108
D11AX14
ATC
[U] tacrolimus; topical
10.2
9.5
18
18
R06AX22
ATC
ebastine; oral
1.8
9.4
176
1068
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
9.3
153
887
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
5.5
9.3
26
48
D11AH02
ATC
pimecrolimus; topical
13.8
9.2
15
11
L04AA01
ATC
[U] ciclosporin; systemic
6.0
9.1
24
41
UJF32
NOMESCO Finland
Coloscopy
1.7
8.9
190
1200
XQ800
NOMESCO Finland
Prick test
2.2
8.7
89
427
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
8.6
239
1625
D11AX15
ATC
[U] pimecrolimus; topical
16.5
8.6
13
8
R01AD09
ATC
mometasone; nasal
1.5
8.4
414
3234
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.2
8.3
87
425
A07AA02
ATC
nystatin; oral
2.6
8.2
57
227
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.5
8.2
36
105
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
6.9
8.1
19
28
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.9
7.8
119
672
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
7.8
134
787
R03AC02
ATC
salbutamol; inhalant
1.5
7.7
457
3684
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
7.7
163
1023
D05AX52
ATC
calcipotriol, combinations; topical
2.8
7.7
47
173
E000006
ATC
NA
2.3
7.7
70
318
L70.0
ICD-10 Finland
Acne vulgaris
4.2
7.6
27
65
J05AB01
ATC
aciclovir; systemic
1.7
7.6
187
1223
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.2
7.6
22
43
D07AC14
ATC
methylprednisolone aceponate; topical
2.6
7.6
53
212
D06BX01
ATC
metronidazole; topical
2.0
7.5
92
477
L71.9
ICD-10 Finland
Rosacea, unspecified
5.1
7.4
22
44
H01.0
ICD-10 Finland
Blepharitis
2.5
7.4
58
245
C03DA01
ATC
spironolactone; oral
2.2
7.4
71
331
D07CC01
ATC
betamethasone and antibiotics; topical
1.9
7.4
116
663
D02AX
ATC
Other emollients and protectives
3.0
7.3
40
138
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.2
522
4365
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
6.9
97
532
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.9
313
2373
L29.9
ICD-10 Finland
Pruritus, unspecified
3.6
6.8
29
83
L04AX01
ATC
azathioprine; systemic
2.6
6.8
48
193
104
Kela drug reimbursment
Thyroid insufficiency
2.2
6.7
66
313
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
6.6
81
420
J02AC02
ATC
itraconazole; systemic
1.7
6.6
151
970
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
6.4
86
464
L65.2
ICD-10 Finland
Alopecia mucinosa
70.3
6.4
7
*
H02AB04
ATC
methylprednisolone; systemic
1.8
6.4
116
691
A02BC02
ATC
pantoprazole; systemic
1.4
6.4
496
4155
P01BA02
ATC
hydroxychloroquine; oral
2.0
6.4
75
384
E000007
ATC
NA
2.3
6.4
59
272
J05AB11
ATC
valaciclovir; oral
1.8
6.2
113
678
N05BB01
ATC
hydroxyzine; systemic
2.2
6.2
61
292
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
3.3
6.0
28
87

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
267
1182
2.72
39.14
1.5
1.4
titre
337.0
557.3
2.57
54
237
(3015171) Extractable nuclear Ab [Units/volume] in Serum
111
326
3.70
32.54
1.2
1.3
u/ml
1.3
1.1
—
7
30
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
381
2175
2.21
30.53
1.5
1.3
u/ml
2.5
1.7
0.24
109
577
(40768443) Skin Pathology biopsy report
89
288
3.29
22.32
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
163
750
2.40
20.91
1.2
1.2
iu/ml
141.5
149.9
0.11
69
306
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
74
222
3.52
20.88
1.4
1.2
u/ml
1.9
2.9
—
6
25
(3013115) Eosinophils [#/volume] in Blood
583
4260
1.88
20.64
8.6
6.2
e9/l
0.2
0.2
3.32
538
3764
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
74
226
3.46
20.32
1.4
1.2
u/ml
3.0
10.0
0.78
14
38
(3013707) Erythrocyte sedimentation rate by Westergren method
756
6047
2.02
19.99
5.3
3.9
mm/h
10.9
10.7
0.19
712
5620
(3006315) Basophils [#/volume] in Blood
563
4107
1.85
19.64
8.6
5.9
e9/l
0.0
0.0
1.01
516
3580
(3001604) Monocytes [#/volume] in Blood
561
4089
1.84
19.61
8.6
5.9
e9/l
0.5
0.5
0.13
516
3564
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
80
263
3.22
19.53
1.7
1.9
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
62
175
3.71
19.15
1.3
1.2
u/ml
1.7
7.7
—
7
12
(3007164) IgA [Mass/volume] in Serum or Plasma
312
1907
1.92
18.92
1.8
1.5
g/l
2.1
2.2
0.80
202
1177
(42870588) Differential panel, method unspecified - Blood
400
2655
1.84
18.70
7.9
6.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
571
4235
1.81
18.34
8.6
5.9
e9/l
2.0
2.0
0.15
533
3765
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
75
247
3.20
18.25
1.4
1.2
u/ml
3.8
41.5
—
6
15
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
814
6789
2.06
17.68
5.4
4.1
pmol/l
15.0
14.5
5.72
759
6258
(3005322) IgE [Units/volume] in Serum or Plasma
132
600
2.38
17.26
1.4
1.3
u/ml
532.0
216.7
1.49
125
560
(3006504) Eosinophils/100 leukocytes in Blood
527
3862
1.77
17.20
8.2
6.0
%
3.3
2.8
5.36
502
3598
(3022096) Basophils/100 leukocytes in Blood
511
3726
1.76
16.85
8.4
6.1
%
0.7
0.7
1.29
487
3480
(3019069) Monocytes/100 leukocytes in Blood
527
3890
1.75
16.52
8.6
6.3
%
8.5
8.2
1.31
504
3657
(3002030) Lymphocytes/100 leukocytes in Blood
537
4024
1.72
15.60
8.4
6.0
%
29.7
29.6
0.04
512
3769
(3001122) Ferritin [Mass/volume] in Serum or Plasma
535
4048
1.69
14.63
3.0
2.8
ug/l
89.3
91.3
0.12
504
3764
(3018010) Neutrophils/100 leukocytes in Blood
525
3983
1.67
13.95
7.9
5.8
%
55.3
56.1
0.86
502
3743
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
466
3435
1.67
13.80
2.8
2.3
nmol/l
78.0
75.5
1.23
427
3134
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
56
189
3.08
13.09
1.4
1.2
u/ml
10.0
45.0
—
7
20
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
479
3612
1.62
12.57
7.4
6.4
mmol/l
1.2
1.2
0.27
392
3046
(40760892) CBC W Ordered Manual Differential panel - Blood
294
1957
1.71
12.55
7.0
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
884
7875
2.03
12.03
6.3
4.8
mu/l
1.8
2.0
0.41
834
7333
(3004616) Nuclear Ab [Presence] in Serum
36
97
3.81
11.92
1.4
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
598
4801
1.61
11.80
10.6
8.7
e9/l
3.8
3.9
0.97
547
4199
(3017181) Myelocytes/100 leukocytes in Blood
122
628
2.07
11.64
5.5
4.3
%
0.9
1.0
0.16
38
172
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
285
1939
1.66
10.97
2.4
2.1
mg/l
2.6
2.9
1.59
258
1658
(3025159) Blasts/100 leukocytes in Blood
110
566
2.06
10.49
5.6
4.4
%
0.0
1.4
0.92
31
134
(3036481) Cortisol [Moles/volume] in Serum or Plasma
139
777
1.92
10.47
2.2
2.1
nmol/l
367.1
369.9
0.06
127
720
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
429
3247
1.56
10.46
6.8
5.8
mmol/l
1.2
1.2
0.06
384
2943
(36660697) Celiac disease serology panel - Serum
140
785
1.91
10.45
1.3
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
114
596
2.03
10.41
5.6
4.4
%
0.2
0.1
0.32
37
155
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
65
269
2.51
10.38
1.8
1.6
g/l
1.1
1.2
1.25
60
254
(3030905) Polymorphonuclear cells [#/volume] in Blood
45
156
2.97
10.08
4.8
3.9
e9/l
4.3
4.2
0.10
45
156
(3002179) Metamyelocytes/100 leukocytes in Blood
110
576
2.02
9.99
5.3
4.2
%
0.5
0.5
0.06
29
125
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
55
4.45
9.84
2.7
2.9
—
—
—
0
0
(3013512) EKG study
287
2005
1.60
9.75
3.4
3.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
350
2563
1.56
9.70
3.1
3.2
mmol/l
2.3
2.4
1.34
306
2289
(3024561) Albumin [Mass/volume] in Serum or Plasma
407
3082
1.54
9.70
5.4
4.6
g/l
36.3
36.3
0.00
389
2887
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
45
161
2.88
9.54
5.2
4.3
%
56.6
57.3
0.12
45
161
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
225
1500
1.64
9.17
1.5
1.6
pmol/l
440.6
26887224.9
1.57
188
1272
(3005719) IgG [Mass/volume] in Serum or Plasma
114
629
1.92
8.90
4.6
2.9
g/l
10.1
10.3
0.13
108
574
(3022948) Iron [Moles/volume] in Serum or Plasma
174
1102
1.70
8.58
2.3
2.2
umol/l
14.4
14.1
0.26
166
1016
(3011436) Histone Ab [Units/volume] in Serum
11
13
8.54
8.47
1.0
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
293
2119
1.54
8.35
2.4
2.1
u/l
137.4
206.5
1.32
275
2000
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
702
6075
1.52
8.21
9.1
6.9
u/l
77.9
77.0
0.20
672
5709
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
378
2896
1.49
8.15
2.0
1.8
pmol/l
95.8
96.9
0.17
198
1504
(3021589) Normoblasts [#/volume] in Blood
461
3674
1.47
8.15
12.2
8.9
e9/l
0.0
0.0
1.12
404
3006
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
323
2403
1.51
8.01
3.3
2.4
u/l
54.4
55.4
0.30
302
2237
(3007853) Bacteria identified in Skin by Aerobe culture
145
892
1.73
7.92
1.7
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
61
3.84
7.83
2.7
2.8
%
11.9
11.2
0.10
12
33
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
23
64
3.65
7.33
1.1
1.1
u/ml
78.2
57.2
—
5
5
(3011412) CD3 cells [#/volume] in Blood
26
79
3.35
7.28
2.5
2.8
e9/l
1.2
1.3
0.20
17
47
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
46
192
2.46
7.27
2.4
1.5
—
—
—
0
0
(3019225) pH of Specimen
117
700
1.76
7.03
2.6
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
291
2182
1.47
6.74
5.3
3.5
estimate
0.0
0.0
0.04
124
774
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
17
41
4.20
6.56
1.1
1.3
u/ml
32.6
20.9
—
5
7
(3028026) IgM [Mass/volume] in Serum or Plasma
87
487
1.86
6.51
2.8
1.9
g/l
1.2
1.4
0.29
82
450
(3032080) INR in Blood by Coagulation assay
343
2668
1.43
6.50
7.6
6.7
inr
2.3
1.1
0.50
117
828
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
185
1273
1.56
6.42
2.8
2.7
mmol/l
2.4
2.4
0.20
163
1131
(3004789) Transferrin [Mass/volume] in Serum or Plasma
150
994
1.60
6.11
2.3
2.2
g/l
2.4
2.4
0.29
142
921
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
138
911
1.60
5.71
2.3
2.3
%
24.2
23.7
0.16
118
793
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
137
906
1.59
5.62
4.3
3.9
%
33.7
32.2
0.91
100
619
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
896
8388
1.64
5.52
15.8
11.6
mg/l
19.6
20.9
0.53
723
6462
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
330
2609
1.39
5.52
3.4
3.1
ng/l
20.1
45.7
0.93
200
1537
(3019309) Folate [Moles/volume] in Red Blood Cells
169
1178
1.52
5.50
1.6
1.7
nmol/l
1195.1
1204.0
0.04
131
892
(3013826) Glucose [Moles/volume] in Serum or Plasma
523
4455
1.36
5.49
5.3
4.5
mmol/l
6.7
6.5
0.73
486
4096
(3045424) Erythrocytes [Presence] in Urine
31
124
2.55
5.41
1.5
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
233
1739
1.44
5.38
4.5
4.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
28
107
2.66
5.35
2.9
3.0
%
0.9
1.0
0.12
22
88
(40761535) Cells panel - Urine sediment
93
567
1.71
5.25
4.7
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
245
1856
1.42
5.19
1.8
2.1
mg/l
1.1
1.0
0.24
184
1396
(3018418) pH of Serum or Plasma
271
2098
1.40
5.06
5.5
3.4
ph
7.4
7.4
0.65
71
402
(4010399)
87
529
1.71
4.96
1.6
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
47
235
2.05
4.92
1.9
1.7
—
200.0
—
0
9
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
124
2.46
4.92
3.9
2.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
26
102
2.59
4.74
1.5
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
466
3958
1.33
4.73
7.0
5.9
umol/l
10.0
10.8
0.95
445
3741
(3021601) Nitrite [Presence] in Urine by Test strip
483
4131
1.33
4.64
5.6
4.5
estimate
0.0
0.0
0.50
126
788
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
91
572
1.65
4.60
4.1
3.2
mmol/l
1.2
1.2
0.49
81
490
(3030313) Adrenal Ab [Titer] in Serum
7
5
14.08
4.58
1.3
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
51
270
1.94
4.57
1.2
1.1
u/ml
12.6
6.0
—
6
41
(3035350) Ketones [Presence] in Urine by Test strip
480
4107
1.32
4.57
4.6
3.3
estimate
0.0
0.0
0.44
122
769
(3037467) Urinalysis macro (dipstick) panel - Urine
640
5706
1.34
4.56
5.1
4.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
133
917
1.52
4.54
1.6
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
162
1165
1.47
4.50
3.2
2.4
ug/g
119.7
113.1
0.14
133
927
(40761511) CBC panel - Blood by Automated count
935
8921
1.71
4.44
14.6
10.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
184
1365
1.43
4.33
1.6
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
484
4170
1.31
4.29
4.5
3.3
estimate
0.0
0.0
0.80
125
762
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
31
3.91
4.26
1.6
2.5
umol/l
45.7
110.1
—
6
18
(3026782) Osmolality of Urine
194
1457
1.41
4.25
3.1
2.5
mosm/kgh2o
543.7
546.3
0.05
173
1239
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
27
4.11
4.17
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
63
2.89
4.07
1.1
1.1
ratio
1.0
1.1
—
7
25
(3012095) Magnesium [Moles/volume] in Serum or Plasma
156
1135
1.44
4.07
4.3
3.9
mmol/l
0.8
0.8
0.02
145
1060
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
49
267
1.88
4.06
1.9
1.6
iu/ml
0.0
0.1
—
7
42
(3020630) Protein [Mass/volume] in Serum or Plasma
80
503
1.64
4.06
3.5
2.5
g/l
66.6
66.8
0.08
73
463
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
77
480
1.65
4.04
2.0
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
84
537
1.62
3.99
3.3
4.0
ng/l
78.5
72.9
0.36
70
479
(3035637) Corticotropin [Mass/volume] in Plasma
24
99
2.46
3.99
1.3
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
124
866
1.49
3.98
1.5
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
140
1005
1.46
3.92
2.0
1.9
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
17
59
2.91
3.91
2.8
3.1
e9/l
0.2
0.2
0.91
12
53
(3018677) aPTT in Platelet poor plasma by Coagulation assay
144
1044
1.44
3.83
2.1
2.8
s
28.8
29.6
1.32
139
1014
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
840
7890
1.40
3.73
4.4
3.9
mmol/l
5.7
5.8
0.32
777
7291
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
17
61
2.82
3.70
2.8
3.1
e6/l
524.3
504.1
0.07
12
54
(3022689) Creatine [Moles/volume] in Urine
8
12
6.71
3.68
2.4
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
45
3.14
3.66
2.2
3.7
u/ml
1189.6
851.0
0.39
14
45
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
214
1678
1.35
3.57
2.9
2.9
ng/l
1168.6
805.5
0.55
181
1393
(40758558) Short blood count panel - Blood
262
2118
1.32
3.55
7.7
6.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
69
2.64
3.48
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
22
94
2.37
3.43
1.2
1.1
—
—
—
0
0
(4062490)
19
76
2.53
3.39
1.5
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
197
1540
1.35
3.35
3.1
2.3
e6/l
8.2
7.7
0.11
176
1348
(3000060) B lymphocytes [#/volume] in Blood
11
32
3.46
3.34
3.3
3.7
e6/l
158.3
262.0
—
6
20
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
65
2.64
3.31
1.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
77
2.50
3.31
1.5
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
48
2.94
3.31
4.4
2.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
977
9516
2.03
3.28
22.9
17.2
e9/l
266.8
259.6
3.07
967
9293
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
926
8899
1.53
3.22
12.7
9.3
u/l
24.9
25.4
0.58
902
8617
(3026008) Bacteria identified in Urine by Culture
289
2397
1.29
3.20
3.2
2.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
28
3.60
3.20
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
25
117
2.17
3.18
1.6
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
977
9523
2.00
3.16
22.7
17.1
pg
30.0
30.1
0.68
972
9402
(3026361) Erythrocytes [#/volume] in Blood
977
9524
2.00
3.14
22.8
17.1
e12/l
4.5
4.5
0.01
966
9284
(3002582) Erythrocytes [#/volume] in Urine
272
2244
1.29
3.13
3.3
2.9
e6/l
56.1
86.7
0.33
220
1698
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
779
7290
1.31
3.11
5.6
4.9
mmol/mol
38.9
38.7
0.27
726
6823
(3030467) Casts [#/volume] in Urine by Automated count
251
2052
1.30
3.10
3.3
2.8
e6/l
0.2
0.4
3.61
199
1525
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
372
3194
1.26
3.09
5.0
3.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
977
9527
1.98
3.09
22.9
17.2
e9/l
6.7
6.7
0.06
964
9285
(3021960) Folate [Moles/volume] in Serum or Plasma
202
1604
1.32
3.08
1.5
1.5
nmol/l
20.6
21.6
0.42
174
1378
(3000963) Hemoglobin [Mass/volume] in Blood
977
9529
1.98
3.05
22.9
17.2
g/l
134.3
134.7
0.45
972
9410
(21494814) CD8 cells/100 lymphocytes in Specimen
10
29
3.47
3.05
2.1
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
197
1561
1.33
3.04
1.3
1.3
iu/ml
18.7
30.0
1.93
56
492
(3004588) Protein electrophoresis panel - Serum or Plasma
65
420
1.59
3.01
3.4
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
21
4.31
3.00
2.1
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
976
9520
1.94
2.99
22.8
17.1
fl
90.2
90.3
0.69
971
9401
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
236
1924
1.30
2.96
1.5
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
878
8376
1.39
2.96
16.0
12.6
mmol/l
139.6
139.6
0.37
861
8155
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
688
6361
1.26
2.89
3.6
3.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
157
1.94
2.87
1.7
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
85
590
1.48
2.86
3.5
3.2
pmol/l
4.5
4.6
0.65
79
521
(3007566) Smooth muscle Ab [Titer] in Serum
38
216
1.79
2.83
1.5
1.3
titre
95.0
80.4
—
6
23
(3034770) Mitochondria Ab [Titer] in Serum
39
225
1.76
2.78
1.5
1.3
—
1510.0
—
0
8
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
125
2.03
2.72
2.4
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
97
698
1.43
2.72
4.6
4.6
u/l
218.3
254.2
1.65
91
665
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
19
4.24
2.68
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
19
4.24
2.68
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
19
4.24
2.68
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
19
4.24
2.68
1.1
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
33
183
1.83
2.68
1.2
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
59
385
1.57
2.65
6.2
6.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
117
877
1.38
2.60
6.7
6.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
320
2746
1.24
2.59
3.9
3.4
e6/l
69.8
89.3
0.27
236
1854
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
25
3.62
2.58
1.2
1.1
%
80.8
98.3
—
9
25
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
25
3.62
2.58
1.2
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
120
905
1.37
2.57
6.8
5.6
mmol/l
1.1
1.1
0.30
115
839
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
20
4.02
2.57
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
862
8236
1.33
2.56
4.8
4.3
mmol/l
2.9
2.9
0.13
800
7684
(3007916) DNA double strand Ab [Titer] in Serum
5
7
7.17
2.55
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
877
8402
1.35
2.55
16.0
12.6
mmol/l
3.9
3.9
0.26
861
8159
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
21
101
2.10
2.54
1.5
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
150
1.89
2.53
1.5
1.8
e6/l
12933.1
16386.8
0.20
20
118
(44806071)
7
16
4.40
2.47
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
63
426
1.51
2.43
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
99
731
1.39
2.42
6.1
3.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
124
1.96
2.42
2.0
1.7
g/l
0.5
0.9
1.05
19
93
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
34
2.96
2.41
1.4
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
34
2.96
2.41
1.4
1.2
—
—
—
0
0
(3020891) Body temperature
40
243
1.67
2.41
7.0
5.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
147
1156
1.32
2.40
1.6
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
27
3.35
2.39
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
177
1.78
2.32
1.2
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
849
8119
1.30
2.32
4.5
4.0
mmol/l
4.8
4.8
0.07
792
7627
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
28
3.23
2.31
1.1
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
314
2718
1.23
2.30
4.1
3.2
u/l
29.0
29.7
0.28
300
2591
(3023520) Reticulocytes [#/volume] in Blood
73
515
1.45
2.30
3.3
3.2
e9/l
66.8
72.0
0.54
60
389
(3003396) Base excess in Arterial blood by calculation
93
687
1.39
2.28
8.5
8.3
mmol/l
1.3
1.3
0.03
82
546
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
23
3.50
2.27
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
816
7773
1.27
2.25
4.1
3.6
mmol/l
1.2
1.3
0.95
762
7238
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
172
1.77
2.23
1.2
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
27
463
0.57
2.21
1.4
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
24
3.35
2.18
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
223
1871
1.25
2.18
3.0
2.5
umol/l
335.2
4975.1
5.71
191
1651
(40768797) Stomach Pathology biopsy report
141
1118
1.30
2.18
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
170
1382
1.28
2.17
2.1
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
54
364
1.51
2.14
1.6
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
130
1.87
2.14
2.8
2.4
%
16.7
16.4
0.15
12
66
(40760888) Immunoglobulin light chains.free panel - Serum
24
130
1.87
2.14
4.7
3.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
183
1504
1.27
2.13
1.3
1.3
u/ml
13.8
11.4
0.17
76
607
(3020191) Ethanol [Moles/volume] in Serum or Plasma
15
68
2.22
2.11
1.6
1.5
promille
0.7
1.2
—
10
56
(3002032) Base excess in Venous blood by calculation
85
627
1.39
2.11
3.8
5.0
mmol/l
2.2
1.9
0.25
73
505
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
349
1.52
2.11
1.5
1.6
—
—
—
0
0
(3010421) pH of Blood
29
168
1.75
2.09
4.7
2.8
ph
7.4
7.4
0.58
24
141
(3017354) Segmented neutrophils/100 leukocytes in Blood
14
62
2.28
2.08
4.0
3.0
%
52.8
51.5
—
9
43
(3020682) Albumin/Creatinine [Ratio] in Urine
235
1995
1.23
2.06
4.4
3.9
mg/mmol
7.5
18.4
0.61
146
1217
(3017732) Neutrophils [#/volume] in Blood
79
579
1.40
2.05
2.1
2.8
e9/l
4.9
4.0
1.08
58
479
(3011397) Hemoglobin [Presence] in Urine by Test strip
223
1884
1.24
2.04
4.4
3.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
26
3.09
2.01
2.1
1.2
ug/l
8.6
7.9
—
8
26
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
26
148
1.78
2.00
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
249
1.59
1.98
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
338
1.50
1.98
2.4
2.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
21
3.35
1.96
1.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
31
187
1.68
1.96
2.0
2.9
umol/l
4.0
7.9
1.49
21
140
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
112
876
1.31
1.92
3.0
3.3
umol/l
5.6
6.6
0.60
92
748
(3012501) Base excess in Blood by calculation
25
143
1.77
1.90
5.0
2.9
mmol/l
1.4
2.5
1.48
14
91
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
22
3.20
1.88
1.9
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
52
2.32
1.88
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
255
2203
1.21
1.87
3.3
3.2
mmol/l
7.8
7.7
0.21
218
1878
(3019150) Specific gravity of Urine by Refractometry
212
1798
1.23
1.87
4.8
3.6
kg/l
1.0
1.0
0.25
27
257
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
841
8083
1.25
1.86
4.4
3.9
mmol/l
1.5
1.5
0.25
787
7550
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
79
2.04
1.86
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
79
2.04
1.86
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
79
2.04
1.86
1.3
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
17
3.54
1.84
1.3
2.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
12
4.18
1.82
1.2
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
12
4.18
1.82
1.4
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
58
412
1.43
1.81
1.5
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
185
1.64
1.77
1.5
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
46
314
1.49
1.76
2.0
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
41
2.45
1.76
1.2
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
27
431
0.62
1.72
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
27
430
0.62
1.71
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
27
430
0.62
1.71
1.4
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
46
0.00
1.71
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
27
429
0.62
1.69
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
235
2036
1.20
1.67
3.2
2.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
31
2.59
1.66
1.4
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
31
2.59
1.66
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
611
5729
1.17
1.65
3.6
3.0
u/l
41.8
41.4
0.04
581
5437
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
25
2.81
1.65
2.9
2.2
ug/l
58.9
94.9
—
7
25
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
807
7754
1.21
1.60
13.2
10.1
ml/min/173m2
86.0
87.5
1.20
692
6267
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
32
2.51
1.60
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
70
2.01
1.59
1.3
1.2
u/ml
0.6
1.2
—
7
21
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
26
2.70
1.58
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
99
1.83
1.58
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
99
1.83
1.58
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
240
1.52
1.56
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
92
1.86
1.56
1.4
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
35
232
1.53
1.56
5.2
7.7
%
0.8
0.9
1.13
35
216
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
78
1.94
1.54
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
78
1.94
1.54
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
78
1.94
1.54
1.3
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
71
1.99
1.54
1.3
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
33
2.44
1.54
1.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
33
2.44
1.54
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
100
1.81
1.53
1.3
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
10
44
2.29
1.53
1.7
3.1
umol/l
27.3
28.8
—
10
44
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
201
1.56
1.52
1.0
1.1
u/ml
12.8
5.3
0.80
20
116
(3043238) Trisomy 21 risk [Likelihood] in Fetus
22
356
0.61
1.51
1.5
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
86
1.87
1.51
4.5
2.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
21
2.87
1.50
3.5
3.0
%
29.2
52.7
—
6
21
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
101
1.80
1.49
1.3
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
45
2.23
1.46
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
263
2327
1.18
1.46
4.2
2.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
102
1.78
1.45
2.7
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
102
1.78
1.45
1.3
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
131
1086
1.24
1.45
2.0
1.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
16
3.14
1.44
1.2
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
22
2.74
1.43
4.2
5.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
22
350
0.62
1.42
1.5
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
25
157
1.61
1.41
1.1
1.1
u/ml
4.5
1.9
—
9
71
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
46
2.19
1.40
1.0
1.1
miu/ml
1348.1
1523.8
—
10
46
(3005033) Fetal Nuchal fold Thickness US
22
348
0.62
1.39
1.5
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
29
2.42
1.39
1.1
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
198
1.53
1.39
1.2
1.8
e6/l
61.2
211.1
1.29
24
153
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
198
1.53
1.39
1.1
1.7
e6/l
14.6
3.8
0.48
20
148
(3027945) Reticulocytes/100 erythrocytes in Blood
90
718
1.28
1.38
3.0
3.1
%
1.5
1.8
1.78
82
650
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
179
1539
1.20
1.38
2.2
2.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
223
1.50
1.37
1.0
1.1
u/ml
3.2
2.4
0.12
16
100
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
41
2.21
1.37
1.9
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
217
1901
1.18
1.36
3.5
3.2
mg/l
402.4
307.7
0.10
131
1173
(3008401) Mugwort IgE Ab [Units/volume] in Serum
29
191
1.53
1.36
1.0
1.1
u/ml
0.8
1.3
0.34
14
90
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
75
1.88
1.34
2.2
1.8
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
41
291
1.43
1.34
2.4
4.5
%
99.6
92.3
1.00
34
272
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
128
1.65
1.34
1.5
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
13
68
1.92
1.33
1.2
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
27
176
1.55
1.32
4.8
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
92
742
1.26
1.31
4.3
2.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
24
2.51
1.30
2.2
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
26
169
1.55
1.29
4.8
3.3
mg/l
21.7
43.8
0.63
21
130
(3034860) Kappa light chains.free [Mass/volume] in Serum
26
169
1.55
1.29
4.8
3.3
mg/l
50.2
73.9
0.24
21
132
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
176
0.51
1.29
3.6
4.1
u/ml
14.1
24.8
—
9
171
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
114
1.68
1.29
2.7
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
235
1.46
1.28
1.8
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
235
1.46
1.28
1.8
1.9
g/l
3.7
3.7
0.12
23
180
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
235
1.46
1.28
1.8
1.9
g/l
7.1
7.4
0.41
24
190
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
55
2.01
1.27
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
22
138
1.61
1.27
6.2
3.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
138
1.61
1.27
1.3
1.1
iu/ml
213.9
205.9
—
8
35
(3014133) Dog dander IgE Ab [Units/volume] in Serum
24
154
1.57
1.26
1.0
1.0
u/ml
17.5
6.2
—
9
61
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
129
1085
1.22
1.26
1.5
1.7
%
1.4
1.4
0.21
110
984
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
14
77
1.83
1.25
1.0
1.1
u/l
44.0
96.9
—
8
54
(3002256) Pathology report gross observation
83
1026
0.79
1.25
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
63
806
0.77
1.25
1.6
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
36
2.23
1.24
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
281
2531
1.15
1.23
2.3
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
349
3192
1.14
1.23
2.8
2.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
56
1.97
1.22
2.8
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
117
1.64
1.18
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
190
1.49
1.17
1.0
1.1
u/ml
3.4
3.4
—
8
49
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
114
955
1.22
1.17
2.6
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
102
1.68
1.16
1.2
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
224
1.44
1.15
1.9
1.9
g/l
3.1
3.1
0.07
24
185
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
3.4
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
80
1.76
1.13
1.1
2.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
30
2.34
1.12
1.4
3.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
40
2.01
1.12
3.4
1.6
—
—
—
0
0
(3000492) Spirometry study
99
824
1.22
1.09
1.7
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
21
2.39
1.09
2.6
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
41
1.96
1.09
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
75
607
1.25
1.07
3.5
2.4
ml/min/173m2
66.5
70.9
0.38
30
225
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
52
1.93
1.06
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
52
1.93
1.06
1.0
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
121
1.58
1.06
1.8
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
86
1037
0.81
1.06
1.3
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.7
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
162
1.49
1.05
2.3
2.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
240
2163
1.14
1.04
2.0
1.9
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
20
130
1.55
1.03
1.0
1.0
u/ml
0.2
0.5
—
8
35
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
60
1.84
1.03
1.0
1.1
—
—
—
0
0
(4024509)
11
60
1.84
1.03
1.8
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
27
188
1.45
1.02
1.5
1.7
nmol/l
48.4
41.0
0.74
27
181
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
5
107
0.46
1.01
1.6
1.1
%
109.0
94.6
—
5
99
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
91
758
1.22
1.01
2.5
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
197
1.43
1.01
1.3
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
107
1.60
1.00
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
17
107
1.60
1.00
1.2
1.3
nmol/l
0.6
0.6
0.11
17
102
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
214
1920
1.15
0.99
2.1
2.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
68
550
1.25
0.99
1.3
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
61
1.81
0.98
5.8
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
24
165
1.47
0.97
3.0
4.0
mmol/l
24.2
25.0
0.32
17
146
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
294
1.34
0.95
1.4
1.5
u/l
16.3
9.2
1.57
29
242
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
141
1.50
0.95
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
18
117
1.55
0.94
2.7
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
69
563
1.24
0.94
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
313
1.32
0.93
9.2
10.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
143
1.48
0.90
1.0
1.1
u/ml
14.0
7.9
—
10
59
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
227
2059
1.13
0.90
1.8
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
135
1.49
0.89
2.6
1.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
42
1.91
0.88
1.0
1.1
u/l
82.5
87.7
—
8
31
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
42
1.91
0.88
1.0
1.1
u/l
22.6
29.3
—
8
31
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
186
1.41
0.88
1.3
1.4
u/ml
303.9
230.0
0.70
12
107
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
95
1.59
0.87
1.1
1.3
nmol/l
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
80
1.63
0.85
2.8
3.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
68
563
1.22
0.83
7.8
8.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
41
521
0.78
0.83
1.5
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
46
1.74
0.82
3.4
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
30
224
1.35
0.80
1.5
1.4
ug/g
307.7
312.1
0.04
15
131
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
259
1.32
0.80
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
181
1.39
0.80
2.5
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
122
1.48
0.80
1.2
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
35
268
1.32
0.80
2.8
1.9
iu/l
6.7
4.4
0.44
11
107
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
81
949
0.84
0.78
1.7
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
199
1809
1.12
0.77
1.7
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
139
1235
1.15
0.76
2.4
2.5
e6/l
0.6
1.1
4.35
85
682
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(4146454)
10
59
1.70
0.76
3.0
2.8
—
—
—
0
0
(3036489) Thrombin time
41
324
1.28
0.76
2.3
3.5
s
20.2
21.4
1.23
27
287
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
227
2086
1.11
0.73
1.8
1.6
mmol/l
1.5
1.3
0.79
190
1796
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
100
1.51
0.73
1.7
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
25
2.00
0.72
1.4
1.1
u/ml
36.8
60.5
—
5
25
(3017569) Oxygen content in Arterial blood
5
25
2.00
0.72
2.6
3.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
92
1.53
0.72
2.9
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
358
3370
1.10
0.71
2.1
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
151
1.40
0.71
3.9
2.4
ug/min
78.0
98.3
0.16
15
95
(3000012) Reticulocyte production index
7
40
1.76
0.71
1.6
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
247
1.31
0.71
1.8
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
88
760
1.17
0.71
2.1
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
26
1.93
0.70
1.4
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
101
1.49
0.70
1.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
18
251
0.71
0.70
1.2
1.3
—
—
—
0
0
(4306422)
19
135
1.42
0.69
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
266
1.29
0.69
3.0
4.5
g/l
0.2
0.4
1.34
11
109
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
187
1.35
0.68
1.2
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
110
1.46
0.68
2.8
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
27
1.86
0.68
2.4
2.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
27
1.86
0.68
1.6
1.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
5
27
1.86
0.68
1.2
1.1
u/ml
0.3
30.5
—
5
18
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
15
102
1.48
0.67
1.7
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
102
1.48
0.67
1.4
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
56
469
1.21
0.64
3.2
5.3
kpa
5.2
5.1
0.16
47
441
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
20
146
1.38
0.64
1.8
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
45
369
1.23
0.64
3.6
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
751
1.16
0.62
1.9
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
58
490
1.19
0.62
2.5
2.2
ug/l
7.7
7.6
0.01
48
437
(3020874) Milk IgE Ab [Units/volume] in Serum
10
63
1.59
0.62
1.0
1.1
u/ml
0.7
4.2
—
5
27
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
271
1.26
0.61
1.8
1.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
30
1.67
0.61
1.4
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
30
1.67
0.61
1.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
122
1094
1.13
0.61
4.4
4.2
ug/l
8.4
2.2
0.51
110
982
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
77
669
1.16
0.60
3.0
4.2
ug/l
4.2
16.3
1.12
60
530
(4133840)
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
53
1.51
0.58
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
346
1.22
0.58
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
98
870
1.14
0.57
4.1
3.8
%
20.6
21.3
0.22
47
378
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
6
35
1.72
0.57
1.5
1.2
pmol/l
11.9
13.5
—
6
28
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
256
1.26
0.57
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
73
1.51
0.56
2.5
2.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
55
1.46
0.56
2.1
1.5
—
—
—
0
0
(44813793)
10
65
1.54
0.55
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
13
90
1.45
0.55
3.4
2.0
mg/l
11.4
26.3
—
7
28
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
125
0.64
0.54
2.3
2.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
187
1.29
0.53
2.6
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
152
1.32
0.52
2.7
2.2
g/l
132.0
130.7
0.07
13
117
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.8
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.8
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
54
463
1.18
0.51
3.2
5.3
ph
7.4
7.4
—
9
52
(3008898) HLA-B27 [Presence]
45
380
1.19
0.50
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
92
1.42
0.50
3.1
1.9
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
41
1.47
0.50
1.0
1.1
u/l
17.8
14.2
—
6
34
(40757494) Bilirubin.total [Moles/volume] in Blood
6
41
1.47
0.50
3.0
2.2
—
21.4
—
0
6
(3014599) Egg white IgE Ab [Units/volume] in Serum
10
67
1.50
0.49
1.0
1.1
u/ml
2.7
1.3
—
5
22
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
12
84
1.43
0.49
1.0
1.2
mg/l
30.9
29.2
—
7
64
(3011288) Drugs identified in Urine by Screen method
38
317
1.21
0.49
2.0
2.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
46
1.53
0.48
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
127
1161
1.11
0.48
2.4
2.7
e6/l
4.6
3.8
0.23
75
611
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
71
627
1.14
0.47
2.6
2.8
ug/l
0.6
0.7
1.28
44
370
(3022313) Gas panel - Capillary blood
29
352
0.82
0.45
3.2
5.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
59
672
0.87
0.45
1.5
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
265
1.21
0.45
1.2
1.2
—
—
—
0
0
(4027681)
10
69
1.45
0.44
1.5
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
10
69
1.45
0.44
2.9
2.4
e6/l
700.8
782.0
—
5
26
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
35
294
1.20
0.43
4.2
3.5
%
0.6
0.7
0.42
35
285
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
78
1.41
0.43
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
78
1.41
0.43
1.6
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
743
7296
1.07
0.42
17.9
14.2
%
13.5
13.5
0.03
734
7146
(3015183) Erythrocyte sedimentation rate
8
58
1.38
0.41
1.1
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
34
1.47
0.40
4.6
3.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
159
1.26
0.40
1.6
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
35
297
1.18
0.40
1.2
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
71
1.41
0.39
1.7
1.5
g/l
1.0
1.0
—
10
71
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
115
1.31
0.39
1.3
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
28
233
1.21
0.39
6.3
7.7
mg/l
1.2
1.3
0.61
28
219
(3025941) Bacteria identified in Stool by Culture
56
496
1.14
0.38
1.5
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
67
1.35
0.38
3.2
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
115
0.69
0.37
1.1
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
143
1.26
0.37
1.4
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
42
1.43
0.35
3.7
2.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
42
1.43
0.35
1.2
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
40
348
1.16
0.35
1.9
1.7
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
43
1.40
0.35
1.0
1.1
u/l
110.0
83.3
—
6
37
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
45
1.34
0.33
2.5
6.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
86
0.70
0.33
2.0
1.6
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
4.5
2.7
nmol/l
140.7
79.9
—
6
46
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
210
1.20
0.33
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
405
3928
1.05
0.33
4.5
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
82
752
1.10
0.32
1.3
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
47
1.28
0.32
1.2
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
92
1.31
0.32
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
96
0.73
0.31
1.0
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
166
1.21
0.30
2.8
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
138
1300
1.07
0.30
4.3
3.3
ng/l
1039.3
408.4
0.48
99
863
(3047181) Lactate [Moles/volume] in Blood
23
194
1.19
0.29
6.8
8.8
mmol/l
1.1
1.2
0.30
23
170
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
50
449
1.12
0.29
3.3
5.3
mmol/l
2.0
1.8
0.15
41
328
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
56
1.25
0.29
2.4
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
185
1.19
0.29
2.3
2.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
76
700
1.09
0.28
2.7
2.4
u/l
33.8
36.5
0.29
68
585
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
44
393
1.13
0.28
1.7
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
117
0.77
0.27
6.3
4.4
%
74.8
63.2
—
9
117
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
131
1.22
0.27
1.3
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
77
1.30
0.26
3.1
2.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
74
0.67
0.26
1.4
1.4
—
—
—
0
0
(3039000) Anion gap in Blood
16
132
1.22
0.25
7.1
11.0
mmol/l
9.5
11.1
1.23
16
120
(3009466) Valproate [Moles/volume] in Serum or Plasma
10
127
0.79
0.25
7.5
6.2
umol/l
396.2
382.9
—
10
114
(3045142) Bone marrow Pathology biopsy report
9
73
1.23
0.25
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
413
0.89
0.25
1.9
1.9
mg/l
1.9
4.5
1.05
22
277
(3023323) Follitropin [Units/volume] in Serum or Plasma
61
561
1.09
0.24
1.3
1.4
iu/l
21.1
27.5
1.02
52
477
(44806118)
12
96
1.25
0.24
2.4
1.7
—
—
—
0
0
(44790048)
12
96
1.25
0.24
2.4
1.7
—
—
—
0
0
(44790047)
12
96
1.25
0.24
2.4
1.7
—
—
—
0
0
(44790049)
12
96
1.25
0.24
2.4
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
16
133
1.21
0.24
7.1
11.0
mmol/l
105.8
105.4
0.14
16
121
(3003694) ABO and Rh group [Type] in Blood
255
2634
0.96
0.23
1.6
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
103
1090
0.94
0.22
2.0
1.9
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
5.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
2.0
—
0
11
(3022670) pH of Venous cord blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(4034850)
29
258
1.13
0.21
9.6
7.9
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
7.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
3.2
—
0.8
—
0
12
(3032868) Hemoglobin electrophoresis panel in Blood
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
24
211
1.14
0.20
3.3
2.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
80
1.25
0.20
1.3
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
25
221
1.13
0.20
1.7
2.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
50
540
0.92
0.19
2.6
2.6
u/ml
115.9
46.7
0.33
50
523
(3021387) Prolactin [Units/volume] in Serum or Plasma
40
436
0.91
0.19
1.7
1.5
mu/l
360.2
303.2
0.40
34
384
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
59
551
1.08
0.18
2.5
2.2
u/l
5492.8
4866.8
0.07
16
251
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
62
1.13
0.17
2.1
3.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
82
1.22
0.17
4.2
2.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
69
0.72
0.17
1.8
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
194
0.87
0.16
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
70
1.14
0.16
1.3
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
183
0.87
0.16
1.6
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
71
1.13
0.16
1.3
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
33
303
1.09
0.15
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
160
1.13
0.14
2.8
7.2
u/ml
0.5
0.4
0.11
11
91
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
99
0.81
0.13
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
170
1.12
0.13
1.6
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
151
1.13
0.13
2.8
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
76
726
1.05
0.13
15.5
18.4
inr
1.1
1.2
0.60
15
105
(3024928) Oxygen saturation in Venous blood
16
142
1.13
0.12
5.0
4.8
—
—
—
0
0
(1002224) Polysomnography panel
35
373
0.94
0.11
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
36
382
0.94
0.10
2.1
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
154
1.11
0.10
2.4
1.2
u/ml
6.1
4.2
—
7
59
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
87
1.15
0.09
1.9
2.6
nmol/l
21.7
23.9
—
10
80
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
145
1.11
0.09
1.1
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
50
523
0.95
0.09
2.4
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
55
527
1.05
0.09
1.0
1.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.0
mg/l
285.5
298.3
—
6
49
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
54
1.11
0.09
1.5
1.1
—
—
—
0
0
(4198724)
6
55
1.09
0.09
1.5
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
55
1.09
0.09
2.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
61
0.82
0.08
1.4
2.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
66
1.06
0.08
2.6
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
77
1.04
0.07
1.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
147
1.09
0.07
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
147
1.09
0.07
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
194
0.93
0.07
2.0
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
40
383
1.05
0.07
1.4
1.3
miu/ml
223.6
246.2
0.18
20
193
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
88
1.02
0.07
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
138
1.09
0.06
1.4
1.1
—
—
—
0
0
(4268621)
9
102
0.88
0.06
5.4
2.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
148
1.08
0.06
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
148
1.08
0.06
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
404
1.04
0.06
2.4
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
266
1.05
0.06
1.0
1.2
—
—
—
0
0
(4281824)
10
90
1.11
0.05
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
44
454
0.97
0.04
1.6
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
50
487
1.03
0.04
1.6
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
40
388
1.03
0.04
1.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
120
1184
1.02
0.04
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
540
5419
0.99
0.03
3.8
3.2
—
—
—
0
0
(4035726)
68
668
1.02
0.03
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
50
489
1.02
0.03
1.6
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
60
609
0.98
0.02
2.5
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
49
482
1.02
0.01
1.6
1.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
194
1948
0.99
0.01
4.2
3.9
%
95.1
95.2
0.02
186
1892
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
374
1.02
0.00
1.4
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
196
1.02
0.00
1.8
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
48
484
0.99
0.00
1.6
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
807
8065
1.00
0.00
14.1
12.4
%
39.4
39.9
0.90
580
6284
(1001926) Buprenorphine [Presence] in Urine by Screen method
38
378
1.01
0.00
1.6
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
189
1.01
0.00
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
189
1.01
0.00
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
305
1.02
0.00
1.2
1.3
—
—
—
0
0
(4094501)
19
185
1.03
0.00
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
155
1.03
0.00
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
53
0.94
0.00
1.2
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
70
1.00
0.00
1.1
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
9.6
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
15.6
—
0
7
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
62
0.97
0.00
2.0
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
25.8
—
0
6
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
2.0
—
9.9
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
9.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
76
0.92
0.00
2.7
2.3
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
7
0.00
0.00
0.0
2.4
—
97.3
—
0
7
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
79
0.89
0.00
1.4
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4212803)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
73
0.96
0.00
1.1
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
60
1.00
0.00
1.2
1.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
4.2
—
4.6
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ALOPECAREATA and mortality.

Females

Parameter HR [95% CI] p-value
L12_ALOPECAREATA 1.002 [0.85, 1.18] 0.981
Birth year 0.996 [0.99, 1.0] 0.338

During the follow-up period (1.1.1998 — 31.12.2019), 192 out of 4322 females with L12_ALOPECAREATA died.

Males

Parameter HR [95% CI] p-value
L12_ALOPECAREATA 0.868 [0.7, 1.08] 0.206
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 1847 males with L12_ALOPECAREATA died.

Mortality risk

Mortality risk for people of age

years, who have L12_ALOPECAREATA.

N-year risk Females Males
1 0.093% 0.179%
5 0.573% 1.007%
10 1.445% 2.59%
15 2.937% 4.999%
20 5.217% 8.461%

Relationships between endpoints

↥

Index endpoint: L12_ALOPECAREATA – Alopecia areata

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data